Literature DB >> 4594038

Normal production of erythrocytes by mouse marrow continuous for 73 months.

D E Harrison.   

Abstract

Marrow cell transplants from old and young control donors were carried in genetically anemic W/W(v) recipients whose anemias were cured by successful transplants. After maximum of 36 months and four serial transplants, marrow cell lines from both old and younger control donors continued to produce erythrocytes normally. The oldest marrow cell lines had produced erythrocytes normally for 73 months. NORMAL ERYTHROCYTE PRODUCTION WAS DEMONSTRATED BY: (1) cure of the anemia in W/W(v) recipients, (2) normal rather than delayed recovery rate of cured recipients after severe bleeding, and (3) normal rather than ineffective response of cured recipients to erythropoietin. Hemoglobin patterns, tested in cured W/W(v) recipients after the first transplantation, showed that at least 90% of the circulating erythrocytes were of the donor type even in donor lines that had produced erythrocytes continuously for 45 months and were recovering from severe bleeding. Concentrations of cells capable of forming macroscopic spleen colonies were more than two orders of magnitude higher in W/W(v) mice cured by old or younger marrow than in uncured W/W(v) mice. Nevertheless, colony-forming unit concentrations declined slowly with successive transplants, and the decline seemed more pronounced at the fourth transplant in old than in younger cell lines.The hypothesis is suggested that senescence is caused by declines in function of only a few vital cell types. The system for comparing old and younger marrow cell lines offers a model for experiments to test this hypothesis and to identify the cell types whose decline causes aging.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4594038      PMCID: PMC427197          DOI: 10.1073/pnas.70.11.3184

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  18 in total

1.  LYMPHOCYTE CONTENT AND PROLIFERATIVE CAPACITY OF SERIALLY TRANSPLANTED MOUSE BONE MARROW.

Authors:  G CUDKOWICZ; A C UPTON; G M SHEARER; W L HUGHES
Journal:  Nature       Date:  1964-01-11       Impact factor: 49.962

2.  THE LIMITED IN VITRO LIFETIME OF HUMAN DIPLOID CELL STRAINS.

Authors:  L HAYFLICK
Journal:  Exp Cell Res       Date:  1965-03       Impact factor: 3.905

3.  The maintenance of the accuracy of protein synthesis and its relevance to ageing.

Authors:  L E ORGEL
Journal:  Proc Natl Acad Sci U S A       Date:  1963-04       Impact factor: 11.205

4.  A direct measurement of the radiation sensitivity of normal mouse bone marrow cells.

Authors:  J E TILL; E A McCULLOCH
Journal:  Radiat Res       Date:  1961-02       Impact factor: 2.841

5.  Long-continued function of normal blood-forming tissue transplanted into genetically anemic hosts.

Authors:  E S RUSSELL; S E BERNSTEIN; F A LAWSON; L J SMITH
Journal:  J Natl Cancer Inst       Date:  1959-09       Impact factor: 13.506

6.  Hematologic and serum electrolyte values of the C57BL-6J male mouse in maturity and senescence.

Authors:  C E Finch; J R Foster
Journal:  Lab Anim Sci       Date:  1973-06

7.  The immune systems of mice reared in clean and in dirty conventional laboratory farms. I. Life expectancy and pathology of mice with long life-spans.

Authors:  F Chino; T Makinodan; W E Lever; W J Peterson
Journal:  J Gerontol       Date:  1971-10

8.  Inactive enzyme molecules in aging mice: liver aldolase.

Authors:  H Gershon; D Gershon
Journal:  Proc Natl Acad Sci U S A       Date:  1973-03       Impact factor: 11.205

9.  Proof of whole-cell implant in therapy of W-series anemia.

Authors:  E S Russell; S E Bernstein
Journal:  Arch Biochem Biophys       Date:  1968-05       Impact factor: 4.013

10.  The response of W-W v and Sl-Sl d anaemic mice to haemopoietic stimuli.

Authors:  D E Harrison; E S Russell
Journal:  Br J Haematol       Date:  1972-02       Impact factor: 6.998

View more
  20 in total

Review 1.  When stem cells grow old: phenotypes and mechanisms of stem cell aging.

Authors:  Michael B Schultz; David A Sinclair
Journal:  Development       Date:  2016-01-01       Impact factor: 6.868

2.  A new mechanism for the aging of hematopoietic stem cells: aging changes the clonal composition of the stem cell compartment but not individual stem cells.

Authors:  Rebecca H Cho; Hans B Sieburg; Christa E Muller-Sieburg
Journal:  Blood       Date:  2008-04-15       Impact factor: 22.113

3.  Proliferative capacity of murine hematopoietic stem cells.

Authors:  S Hellman; L E Botnick; E C Hannon; R M Vigneulle
Journal:  Proc Natl Acad Sci U S A       Date:  1978-01       Impact factor: 11.205

Review 4.  Cellular aging--clonal senescence. A review (Part I).

Authors:  G M Martin
Journal:  Am J Pathol       Date:  1977-11       Impact factor: 4.307

Review 5.  Cell culture aging.

Authors:  M Reff; E L Schneider
Journal:  Mol Cell Biochem       Date:  1981-05-26       Impact factor: 3.396

6.  Relationship between donor age and the replicative lifespan of human cells in culture: a reevaluation.

Authors:  V J Cristofalo; R G Allen; R J Pignolo; B G Martin; J C Beck
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-01       Impact factor: 11.205

7.  Hematopoietic stem cells with high proliferative potential. Assay of their concentration in marrow by the frequency and duration of cure of W/Wv mice.

Authors:  D R Boggs; S S Boggs; D F Saxe; L A Gress; D R Canfield
Journal:  J Clin Invest       Date:  1982-08       Impact factor: 14.808

Review 8.  The role of growth factors in haemopoietic development: clinical and biological implications.

Authors:  C P Daniel; T M Dexter
Journal:  Cancer Metastasis Rev       Date:  1989-12       Impact factor: 9.264

9.  The relationship between in vitro cellular aging and in vivo human age.

Authors:  E L Schneider; Y Mitsui
Journal:  Proc Natl Acad Sci U S A       Date:  1976-10       Impact factor: 11.205

Review 10.  Stem cell aging: survival of the laziest?

Authors:  Christa Muller-Sieburg; Hans B Sieburg
Journal:  Cell Cycle       Date:  2008-12-16       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.